DocRX

What DocRX does

DocRX is a private, for-profit healthcare products company operating as a manufacturer, wholesaler, and distributor. Founded in 2008 and headquartered in Mobile, Alabama, the company employs 51-100 people and operates through the domain docrx.com. The company is described at a high level as a vertically integrated healthcare products business covering manufacturing through distribution, though specific product categories, therapeutic areas, customer types, and pricing mechanics are not disclosed in the available input data. The company's public web presence is limited — docrx.com currently displays only a verification/loading screen — and no detailed product catalog, certifications, regulatory registrations, management team, or financial metrics are available.

The only documented strategic action in the input is a December 2025 partnership with Orsini, a rare disease specialty pharmacy solutions provider. The collaboration is designed to support international patients receiving complex specialty therapies in the United States, with emphasis on logistical coordination and language support for medical travelers with rare diseases. This positioning suggests DocRX is extending its distribution reach beyond a purely domestic channel into the cross-border rare disease treatment ecosystem, leveraging Orsini's specialty pharmacy capabilities. No revenue, funding history, customer roster, M&A activity, or product launch data are disclosed in the source material, which materially limits the depth of operational assessment.

Name

DocRX

Website

https://docrx.com

Company type

Private

Founded year

2008

Headcount range

51–100 employees

Short description

DocRX is a private Mobile, Alabama-based healthcare products company founded in 2008 that manufactures, wholesales, and distributes healthcare products, employing 51-100 people. Its most recent strategic action is a December 2025 partnership with rare disease pharmacy Orsini to serve international patients in the U.S.

Ownership category

akta.pro rank

Headquarters

HQ city

Mobile

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales

Core offering

DocRX is a manufacturer, wholesaler, and distributor of healthcare products. The company produces healthcare goods and supplies them through wholesale and distribution channels to downstream healthcare buyers, with strategic extensions into specialty rare-disease therapies via its partnership with Orsini.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Products (manufacturing, wholesale, and distribution) Manufactured healthcare products supplied via wholesale and distribution channels to healthcare buyers such as pharmacies, hospitals, and care providers.
• Specialty Rare-Disease Therapy Distribution (via Orsini partnership) Distribution support for complex and specialty rare-disease therapies delivered to international medical travelers in the U.S., provided in collaboration with Orsini (a rare disease pharmacy solutions provider).

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• OrsinicoreStrategic or Co-development Partner · 8 December 2025Orsini, a rare disease pharmacy solutions provider, has partnered with DocRX (Dos Rx) to support international patients receiving complex care in the U.S. The collaboration aims to facilitate seamless access to specialty therapies for travelers with rare diseases, improving logistical and language support. This partnership is expected to expand access and improve treatment continuity for medical travelers to the U.S.

Recent moves1 record

Expansion highlights3 records

Broad incumbents

• CVS Specialty (CVS Health): Specialty pharmacy unit of a major integrated pharmacy and payer; comparable to DocRX as a specialty drug distributor and care provider for patients on complex/rare-disease therapies.
• Cardinal Health: Large-scale pharmaceutical and medical product distributor with a specialty solutions arm; comparable to DocRX in the pharmaceutical wholesale/distribution core business.
• McKesson Corporation: Largest U.S. pharmaceutical and medical product distributor; comparable to DocRX as a wholesale/distribution peer operating across drug and healthcare product lines, though at vastly greater scale and breadth.
• Accredo (Cigna/Express Scripts): Specialty pharmacy arm of a major payer/PBM; comparable to DocRX as a high-volume specialty pharmaceutical distributor serving patients on complex, often rare-disease, therapies.
• Walgreens Specialty Pharmacy (Walgreens Boots Alliance): Retail-attached specialty pharmacy network; comparable to DocRX as a specialty pharmaceutical distributor serving patients on complex therapies, though embedded within a much larger retail footprint.
• Cencora (formerly AmerisourceBergen): Major pharmaceutical distributor and specialty services provider (including through its PharmaLex/World Courier businesses); comparable to DocRX as a drug wholesaler/distributor operating specialty distribution capabilities.

Direct peers

• Amber Specialty Pharmacy: Independent specialty pharmacy focused on complex conditions including rare and chronic diseases; comparable to DocRX because both distribute specialty pharmaceuticals and serve patients with high-touch therapy needs.
• PANTHERx Rare Pharmacy: Specialty pharmacy focused exclusively on rare and orphan disease therapies; comparable to DocRX because both operate in the high-touch specialty/rare-disease distribution channel for complex medications.
• Diplomat Pharmacy (Optum Specialty Pharmacy): Specialty pharmacy serving patients on complex and chronic therapies; comparable to DocRX because both distribute specialty pharmaceuticals requiring elevated handling, patient services, and payer coordination.
• Orsini Specialty Pharmacy: Rare disease specialty pharmacy and direct partner of DocRX; comparable because both serve complex/rare-disease therapy distribution and support international patient access to U.S. specialty medications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/DocRXInc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DocRX